3SOF

SOME FUNDAMENTALS ABOUT INSTITUTIONAL OWNERSHIP


...have a look to the following numbers.
You can see some interesting facts about increased or decreased institutional ownership.

The "Top25" holders in VION held 29,54 Mio Shares.

> 12 increased Pos./ 6.362.532 Shares were bought in last actions

> 10 decreased Pos./ 4.177.701 Shares were sold in last actions

> 3 unchanged Pos./ no buying or selling action announced since 31/03/2005.


The real trend is they are accumulating Shares in a size 1,5x bought to sold shares.

Think about!


good luck to longs

The volume is really light for a stock pushing out of the top band but still to watch as it may improve with BO at 2.90 but note the 200-day EMA overhead

Weightlifter, the stock did go up in price to around $3.00 when you
made the pick on 09  June. It has came dowm since then.
Way oversold. Indicators are turning north. Stochasticis coming out of oversold area.

Support @ $1.62
Resistance @ $1.79...1.92...2.02

Recent CandleStick Analysis
Very Bullish
Dec-30-2005 Bullish Engulfing 

Technicals
Last Price Quote is:
-2.93%below 13-day EMA
-13.66%below 50-day EMA
RS Rating: 7 

Fundamentals
Key Data:
Market Cap (M): $108.87 
P/E Ratio: NA 
PEG Ratio: N/A 
Next Earnings: 03/14/2006
Last Analyst Rating: Buy

Double bottom play!

In at 1.97 last week. Some big buys (100k) yesterday. Recently received orphan drug status for their drug  in clinical trials in the EU and fast track approval for certain indications in the US. Expecting FDA news by the end of the month.

Vion Pharmaceuticals Receives Orphan Drug Designation for Cloretazine(R) in Europe for Treatment of Acute Myeloid Leukemia

http://biz.yahoo.com/prnews/060123/nym040a.html?.v=1

(Just noticed 2 other threads on Vion already started after posting this, sorry)

News out

Vion Pharmaceuticals to Host Conference Call
Monday January 30, 4:15 pm ET

NEW HAVEN, Conn., Jan. 30 /PRNewswire-FirstCall/ -- Vion Pharmaceuticals, Inc. (Nasdaq: VION - News) will hold a conference call and simultaneous webcast on Tuesday, January 31, to provide an update on the clinical development of its lead anticancer agent Cloretazine®. The call will begin at 8:45 a.m. eastern time.

http://biz.yahoo.com/prnews/060130/nym216.html?.v=28

Should be interesting!

Vion Pharmaceuticals Announces Plans to Conduct a Pivotal Phase II Trial of Cloretazine(R) in Elderly Poor-Risk Acute Myelogenous Leukemia

http://biz.yahoo.com/prnews/060131/nytu033.html?.v=41

Up pre market last 2.10

Bid 2.10 Ask 2.65

VION makes me seasick just looking at the chart.(I am slightly green on this stock )

Huge volume yesterday, 600% increase 4 million shares traded.

Could be ready to make a move!

Vion has got news today...
It could rise today...
Low price now 1.55

[audio] Vion June 2006 Conference Call (recorded earlier today)


• Vion June 2006 Call scheduled for 8:45 am ET today
CCBN (Wed 8:45am) 
• InPlay: Vion Pharma provides update for clinical and preclinical programs
Briefing.com (Wed 7:09am) 
• Vion Pharmaceuticals Provides Update for Clinical and Preclinical Programs
PR Newswire (Wed 7:00am) 

today... we're @ 1.8 $

Applaud you Idfix...Look at the chart...

Hi Seb...watch !...your expectations were totaly correct!




Cheers,
Id...

 

VION continues its run....1.78 yesterday...

Time to get in? I believe so... buy and hold


Cheers

Vion Pharmaceuticals to Present at Fortis Bank Biotechnology Conference
Monday April 23, 8:00 am ET


NEW HAVEN, Conn., April 23 /PRNewswire-FirstCall/ -- Vion Pharmaceuticals, Inc. (Nasdaq: VION - News) announced today that it would be making a corporate presentation at the 7th Annual Fortis Bank Biotechnology Conference on April 25, 2007. The conference is taking place at The Four Seasons Hotel, Park Lane in London, England.


The presentation will be at 9:45 a.m. EDT (2:45 p.m. British Summer Time (BST). The slides from the presentation will be posted to Vion's website, http://www.vionpharm.com, at 9:45 a.m. EDT on April 25, 2007.